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ABSTRACT: The success of synthetic bone implants requires good
interface between the material and the host tissue. To study the
biological relevance of ﬁbronectin (FN) density on the osteogenic
commitment of human bone marrow mesenchymal stem cells (hBM-
MSCs), human FN was adsorbed in a linear density gradient on the
surface of PCL. The evolution of the osteogenic markers alkaline
phosphatase and collagen 1 alpha 1 was monitored by immunohis-
tochemistry, and the cytoskeletal organization and the cell-derived FN
were assessed. The functional analysis of the gradient revealed that the
lower FN-density elicited stronger osteogenic expression and higher cytoskeleton spreading, hallmarks of the stem cell
commitment to the osteoblastic lineage. The identiﬁcation of the optimal FN density regime for the osteogenic commitment of
hBM-MSCs presents a simple and versatile strategy to signiﬁcantly enhance the surface properties of polycaprolactone as a
paradigm for other synthetic polymers intended for bone-related applications.
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■ INTRODUCTION
Imparting biomimetic characteristics to the implant surface of
synthetic materials is essential to reinforce the interaction
between implant and host tissue.1 Synthetic scaﬀold materials
are typically characterized by uniform and reproducible
properties, but they lack the bioactivity and positive host tissue
response associated with extracellular matrix (ECM)-derived
scaﬀolds.2,3 Weak tissue-implant integration often leads to low
mechanical stability, inﬂammation and, ultimately, rejection of
the implants, compromising the eﬃcacy of therapies.4 Coating
of synthetic implants with natural adhesion proteins of the
ECM may contribute to the enhancement of the interactions
between the implant and the host tissues, which ultimately
strengthens the tissue-implant interface. The main protein of
bone is collagen type 1 (COL1).5 However, the COL1
polymerization was shown to require the presence of FN.6,7
This requirement may implicate FN in the formation of matrix
defects such as those seen in osteogenesis imperfecta, which is
caused by qualitative or quantitative deﬁciencies in COL1, and
results in bones prone to fracture.8 Furthermore, there is
evidence that FN is synthesized and deposited during tissue
repair9 where early recruitment and commitment of osteoblast
precursors, such as mesenchymal stem cells (MSCs), occurs.
Human bone marrow-MSCs (hBM-MSCs) can diﬀerentiate
into a variety of adult cell types, such as osteoblasts,
chondrocytes or adipocytes.10 Hence, the trigger and support
of the osteogenic diﬀerentiation of hBM-MSCs by the scaﬀold-
material at the lesion site, is critical for the success of the bone
tissue regeneration. Recent advances have shown that, along
with soluble factors, biophysical, biomechanical, and cell
adhesion protein cues can also be strong regulators of stem-
cell fate.11−13 The presence of FN is not bone ECM-speciﬁc, so
it was hypothesized that the distinctive role of FN in the
osteogenic commitment of hBM-MSCs could be related to a
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speciﬁc optimal density of this protein in the ECM-micro-
environment. Surface gradients allow for the screening of
speciﬁc physicochemical properties, and have been successfully
applied in a number of cell-biology studies.13−16 This approach
allows the identiﬁcation of the gradient region that elicits the
optimum cell response of interest, while keeping the other
experimental conditions consistent. The advantages of this
method include determining the limits by which each surface
characteristic is eﬀective, minimizing cell-culture variations,
decreasing the cost of consumables, and reducing the
probability of methodological errors due to the large number
of samples that would otherwise be necessary to test similar
hypotheses. The later advantage is particularly important for
the study of stem cell populations, which may be diﬃcult to
obtain in large numbers and are signiﬁcantly aﬀected in their
stemness by the in vitro expansion step.17
In this study were engineered 10 mm-long gradients,
consisting of a linear surface-density arrangement of human
plasma-isolated FN adsorbed on polycaprolactone (PCL). The
surface was further passivated using bovine serum albumin,
which is known to inhibit MSC adhesion.18 This system
allowed for the systematical study of the eﬀect of FN density,
varying from densely packed to sparse molecule distributions,
on the biological performance of hBM-MSCs. The bioperform-
ance of each surface density area was assessed by the analysis of
the cell adhesion and proliferation, production of endogenously
cell-derived FN (endoFN), and expression of the osteoblastic
markers alkaline phosphatase (ALP) and collagen type 1 alpha
1 (COL1A1). To the best of our knowledge, this is the ﬁrst
systematic study reporting the density-speciﬁc inﬂuence of
adsorbed human FN on the osteogenic commitment of hBM-
MSCs.
■ MATERIALS AND METHODS
Surface Preparation. Silicon wafers with a native oxide coating
(Si-Mat Silicon Materials, Germany), 1 cm × 1 cm, were sonicated
twice for 10 min in toluene, then twice for 10 min in 2-propanol, and
ﬁnally exposed to oxygen plasma for 2 min (PDC-32G instrument,
Harrick, Ossining, NY, USA). The thickness of the silicon oxide layer
was then measured using variable-angle spectroscopic ellipsometry
(VASE; described below). The polycaprolactone (PCL; TONE, Union
Carbide Chemicals and Plastics Division; NJ, USA) solution was
prepared at a concentration of 3 g/L in tetrahydrofuran (Sigma-
Aldrich). Ultrathin polymeric ﬁlms were obtained by spin-coating
(Fairchild Technologies, 1001, Germany) of the silicon wafers at room
temperature for 70 s at 4000 rpm. The substrates were then annealed
overnight at 90 °C and submitted to air-plasma (a distinct PDC-32G
instrument, Harrick, Ossining, NY, USA) for 34 s, at 60 W and 0.1
mbar, to proceed to the sterilization of the sample.
Polycaprolactone (PCL) Surface Characterization. Static
contact-angle measurements were performed with 4 μL water drops,
at room temperature, with a NRL contact-angle goniometer (model
100−00−230, Rame ́ Hart Inc.; NJ, USA). Six measurements were
carried out for each sample.
Thickness measurements were performed before and after PCL
spin-coating, as well as after air-plasma treatment, using a variable-
angle spectroscopic ellipsometer (VASE) (M-2000F, L.O.T. Oriel
GmbH, Germany) equipped with a focusing probe, at room
temperature, with an incidence angle of 70° on several spots of each
wafer, over the spectral range of 370−994 nm. The resulting
measurements were ﬁtted with the WVASE32 analysis software to a
multilayer model for a silicon substrate, silicon oxide layer and a
polymer adlayer with the optical properties of a Cauchy ﬁlm.19
Isolation of Fibronectin (FN) from Human Plasma. FN was
isolated from human plasma (Zürcher Blutspendedienst SRK)
following a previously published gelatin-sepharose chromatographic
method.20 Brieﬂy, after adding 2 mM phenylmethylsulfonyl ﬂuoride
and 10 mM EDTA to the fresh human plasma, the plasma was
centrifuged at 15000 g for 40 min. Plasma was passed to the gelatin
Sepharose 4B column (Pharmacia) and the ﬂow-through was directly
passed to the Sepharose 4B column (Sigma-Aldrich). The gelatin
column was then washed with 2 mM phenylmethylsulfonyl ﬂuoride
and 10 mM EDTA in PBS (Fluka Chemicals, Buchs). Before elution,
the gelatin column was washed with 1 M NaCl, 1 M urea, and ﬁnally
FN was eluted from the column with 6 M urea. Isolated FN was stored
at −20 °C in 6 M urea. Before use for surface coating, the isolated FN
was dialyzed against PBS (for 16 h at room temperature). Dialyzed FN
was further stored at −20 °C for not more than 3 months.
Alexa-633 FN Labeling. FN (2 mg/mL in PBS) was labeled using
ﬂuorescent marker Alexa-633-NHS (Invitrogen) according to the
manufacturer’s instructions. Brieﬂy, 1:10 volume of 1 M bicarbonate
buﬀer (pH 8.0) was added to the FN solution to increase the reactivity
of the NHS ester. Alexa-633-NHS was dissolved in DMSO (10 mg/
mL) and added to the protein solution to reach a ﬁnal concentration
of 1 mg/mL. The solution was incubated in the dark at room
temperature for 2 h and then dialyzed against PBS. Finally, the labeled
FN was stored at −20 °C in the dark.
Production of Gradients Using the Labeled-FN. Transmission
interference adsorption sensor (TInAS) measurements21 were used to
determine the adsorption kinetics of FN on PCL-coated substrates.
TInAS sensors (which possess a silicon oxide surface coating) were
spin-coated with PCL using the same procedure as described above in
Surface Preparation. The sensors were equilibrated in a 10 mM
solution of phosphate-buﬀered saline (PBS) (Fluka Chemicals,
Buchs), and then a solution of 0.04 mg/mL of FN in PBS was
introduced at a constant ﬂow rate of 20 μL/min. This ﬂow rate was
determined in previous studies to correspond well to gradient dipping
conditions, preventing depletion of the buﬀer without artiﬁcially
accelerating the adsorption. The adsorption curve was characterized by
rapid initial adsorption of the protein onto the surface, which slowed
down as the proteins rearranged themselves on the surface until no
further adsorption took place. The results showed that for a
concentration of 0.04 mg/mL of FN, the saturation level was obtained
after a controlled immersion time of 60 min. The sensors were then
rinsed with PBS without variation in the measured optical thickness.
The FN adsorption curve was translated into a dipping program
designed to yield a linear gradient. This program was followed by a
computer-controlled motor arm (OWIS, Staufen, Germany) to
immerse the PCL-coated substrates into a beaker with the Alexa
633-FN solution at a controlled rate. Following FN-gradient
production, the substrates assigned for characterization were
immediately rinsed in PBS and ultrapure water, and dried under a
nitrogen steam. The gradients assigned for cell culture were, instead,
rinsed in PBS and incubated for 1 h at room temperature in a solution
of 4% bovine serum albumin (BSA; Sigma, A6003), after which the
samples were rinsed again twice and stored at 4 °C in PBS until cell
seeding.
Characterization of the FN Gradient. The linearity of the
produced FN gradient was determined by VASE measurements, taken
2 mm apart along the length of the gradient, before and after protein
adsorption, using VASE equipped with a focusing probe with an
incidence angle of 70°, at room temperature over the spectral range of
370−994 nm. The resulting measurements were ﬁtted with the
WVASE32 analysis software to a multilayer model for a silicon
substrate, a silicon oxide layer (of the measured thickness prior to PCL
treatment), and PCL and FN adlayers with the optical properties of a
Cauchy ﬁlm.19 Microscopy imaging was used to qualitatively conﬁrm
the presence of the labeled FN gradient. Quantitative analysis of the
intensity of the ﬂuorescent signal was determined by the histogram
algorithm in ImageJ software22 (Wayne Rasband, National Institutes of
Health, USA) before and following the cell-culture. All measurements
were plotted as mean ± standard error.
Isolation of Human Bone Marrow Mesenchymal Stem Cells
(hBM-MSCs). The isolation of primary human bone marrow
mesenchymal stromal cells (hBM-MSCs) from femur-derived bone
marrow samples was accomplished after the informed consent of three
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independent donors (67−82 years old). The protocol was approved by
the ethics board of the Kantonspital St. Gallen, Switzerland (EKSG
08/14). As described before,23 bone-marrow samples were incubated
in isolation medium (25 mM HEPES (Fluka, 54459), 128.5 mM NaCl
(Fluka, 71380), 5.4 mM KCl (Fluka, 60130), 5.5 mM d(+)-glucose
(Sigma, G7528), 51.8 mM d(+)-saccharose (Sigma, 84097), 0.1%
bovine serum albumin (Sigma, A6003)) overnight at 4 °C. The
protocol proceeded with the centrifugation of the bone marrow at
110g for 15 min at 4 °C to remove fat tissue in the supernatant. The
cell solution was ressuspended in isolation medium, ﬁltered by a 200
μm polyethylene terephthalate (PET) ﬁlter, and centrifuged. After the
supernatant had been discarded by aspiration, the cell pellet was
resuspended in basal growth medium (α-MEM supplemented with
10% fetal bovine serum (FBS; Lonza), 1% penicillin−streptomycin−
neomycin antibiotic mixture (100 × ) (PSN; Gibco), 1 ng/mL
ﬁbroblast growth factor 2 (FGF-2; Sigma, F0291)). The cell number
in solution was determined and the cells seeded at a density of 1 × 107
cells in a T75 culture ﬂask in basal growth medium. After 24 h, the
nonadherent cells were removed and the medium was changed twice
weekly from then on. Cells were subcultured at subconﬂuence and
further seeded at passage one or two.
Seeding and Culture of hBM-MSCs. hBM-MSCs were seeded as
a concentrated drop at 5000 cells/cm2 in basal growth medium on FN
gradient samples (in circular wells of nonadherent tissue culture
polystyrene of internal diameter of 21.40 mm) and on cell-adherent
tissue culture polystyrene well-plates (TCPS). The cell attachment
occurred for 4h, after which fresh medium was added to complete 1.5
mL of medium per well. Twenty-4 h later, the basal growth medium
was aspired and substituted by standard osteogenic induction medium
(α-MEM supplemented with 10% FBS, 1% PSN, 50 mM ascorbate-2-
phosphate (Sigma, A8960), 2 mM β-glycerophosphate (Sigma, G-
9891), 10 nM 1,25-dihydroxyvitamine D3 (Sigma, D-1530), and 10
nM dexamethasone (Sigma, D-4902)), both in the FN gradient
samples and in the TCPS.
Immunoﬂuorescence. At each time point, cells on the control
material TCPS and on the FN gradient samples were removed from
the incubator, gently washed twice in prewarmed PBS and ﬁxed and
permeabilised with 4% paraformaldehyde/0.2% Triton X-100 for 8
min. The samples were then thoroughly washed in PBS without
glucose (Gibco, 18912−014) and placed in 1% fetal calf serum/5%
goat serum for 30 min at room temperature, to block nonspeciﬁc
binding sites. Following the incubation period the samples were rinsed
(twice) in PBS without glucose and incubated with the antibodies. The
primary antibodies, recommended for detection of antigens of human
origin, were used as follows: alkaline phosphatase (ALP) (1:1000,
Developmental Hybridoma Bank, B4−78), collagen type 1 alpha 1
(1:200, Santa Cruz Biotecnology, 8784) and ﬁbronectin (1:100, Santa
Cruz Biotechnology, 6953), in 3% BSA in PBS for 1 h at room
temperature (RT). The samples were then rinsed (twice) in PBS
without glucose and cell nuclei were ﬂuorescently stained by 4′-6-
diamidino-2-phenylindole (DAPI; 1:1000, Sigma-Aldrich, D9542) in
3% BSA in PBS, for 1 h at RT, combined with the secondary
antibodies: Alexa Fluor 546 goat antimouse IgG (1:400, Molecular
Probes, A11030) and Alexa Fluor 488 goat antirabbit IgG (1:400,
Molecular Probes, A11034) for ALP and COL1A1 reactivity; and
donkey antigoat antibody Cy3 conjugate (1:400, Merck Millipore,
AP180C) for human ﬁbronectin detection.
Independent Detection of Adsorbed FN and Endogenously
Cell-Derived FN. The FN gradient was fabricated using Alexa-633
conjugated plasma-FN (Figure 1A) which allowed direct and
quantitative measurement of the FN content adsorbed on the PCL-
coated substrate, on the ﬁrst, seventh and 14th day/time points
(Figure 2). Additionally, to assess the endogenously cell-derived FN
Figure 1. (A) Acquisition by ﬂuorescence microscopy (FM) of the ﬂuorescence signal of ﬁbronectin (FN) along the 10 mm surface of
polycaprolactone (scale bar = 1 mm), conﬁrming the conﬂuent to sparse distribution of FN, as indicated by the inset drawings. (B) Quantiﬁcation of
the optical thickness of FN measured by variable-angle spectroscopic ellipsometry, and of the ﬂuorescence intensity of FN measured by FM. (C)
Mass of FN along the gradient, calculated from the optical thickness measurements obtained by transmission interference adsorption sensing, using
the de Feijter equation.24
Figure 2. Variation in the ﬁbronectin (FN) density on polycapro-
lactone-coated wafers prior to cell seeding (day 0) and at the 7th and
14th days of cell culture, as a function of the intensity of the FN
ﬂuorescence signal. The statistical signiﬁcance of the measurements
was p(*) < 0.01 and p(x) < 0.05.
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(endoFN) on the samples it was necessary to proceed with the
immunolabeling of the (total) FN content, by a primary anti-FN
antibody combined with a secondary antibody (above detailed).
Unexpectedly, the acquisition of the ﬂuorescence signal coming from
the total FN content was not able to detect the originally adsorbed
FN. Example images from the 14th day are shown here: originally
adsorbed Alexa-633 FN (A), and antibody antihuman FN (B). When
merging both channels, no superposition of red and green is evident
(C), showing that the originally adsorbed FN, independently
conﬁrmed to still be present via Alexa-633 detection, was not
observable by this method. This may result from the comparably
higher concentration of ﬂuorochromes bounding to and brightening
the multiple-layers of the endoFN (compared to the sparse-to-
monolayer-like distribution of the originally adsorbed FN), which
ultimately allowed for the independent observation of the endoFN on
the samples. If one wished to detect the originally deposited FN
through this channel, one would have to increase the intensity of the
laser, superexposing the ﬁbers of the endoFN on top of the originally
adsorbed FN.
Fluorescence Microscopy and Quantiﬁcation of the Inten-
sity of the Fluorescent Signal. Microscopy was performed by an
automated ﬂuorescence microscope (Zeiss Axiovert 200M), using the
DAPI, Alexa Fluor 488, Alexa Fluor 546/Cy3 and the Alexa 633
emission ﬁlter settings. A 20x objective was used to image and capture
by automated acquisition the 10 mm length of the gradient. Four
millimeters in the perpendicular axis were also captured, and the set of
images stitched, as a mosaic, by the AxioVision 4.8.1 software available
with the microscope. To allow for the comparison of the intensity of
the ﬂuorescence signal of the ALP, COL1A1, and endoFN, we kept
the microscope settings constant after the determination of the
optimal conditions to capture the brightest sample of each biomarker
set. The images were then analyzed by ImageJ software,22 which
quantiﬁed the variation of the ﬂuorescence intensity within each
gradient sample (per mm2) and TCP controls. For that, the
ﬂuorescence signal corresponding to the immunodetection of ALP,
COL1A1 and FN was converted into the gray scale and the mean
intensity of the gray values per mm2 was calculated by the histogram
algorithm. The background signal was also measured and, if diﬀerent
from zero, subtracted from the original measurement to generate the
accurate intensity of expression of each biomarker. Finally, to
determine the intensity of the ﬂuorescent signal of ALP, COL1A1
and FN normalized to the cell count, the cell nuclei per square
millimeter was also quantiﬁed. For that, the mean average of the nuclei
± standard deviation was calculated, using the scale bar as a reference,
and a band size ﬁlter applied to exclude any artifacts, such as dust
particles. Moreover, the nuclei image was segmented by the watershed
algorithm to prevent overlapping nuclei to be counted as single cells.
The cytoskeletal area along the length of the FN gradient and on
TCPS was directly calculated by the space occupied by the F-actin per
mm2 of single cells in the image. However, when the agglomerate of
cells did not allow for the direct measurement, the total cytoskeletal
area was divided by the number of nuclei in the respective space. All
normalized results are presented as the mean ± standard error of the
mean value of the replicates.
Statistical Analysis. Statistical analysis was performed using
GraphPad (version 5.01 for Windows, San Diego, California). Two-
way ANOVA test followed by Bonferroni posttest were performed to
analyze the eﬀect of substrate (TCPS or FN gradients) and culture
time (in days) on the (1) cell density and distribution, (2) normalized
expression of the osteogenic markers ALP and COL1A1, (3)
normalized expression of endoFN and (4) cytoskeleton area. The
signiﬁcance level of the threshold was set at 0.05. Thus, p (probability)
values lower than 0.05 were considered to describe statistical
signiﬁcance.
■ RESULTS AND DISCUSSION
Linearly Varying FN-density Gradient on PCL, and the
FN Rearrangement Throughout the Study. To study the
osteogenic commitment of hBM-MSCs on variable FN surface-
density, we engineered a linear FN density-gradient onto PCL.
The kinetics of FN adsorption onto PCL were measured using
a previously published in situ transmission interference
adsorption sensing (TInAS) technique.21 The resulting
adsorption curve was inverted and translated into a dipping
program. Substrates were immersed in FN solution by a
computer-controlled arm following the generated dipping
program, yielding a linear density gradient over the length of
the substrates. The production of the FN gradient at the surface
of the PCL-coated wafers was conﬁrmed by ﬂuorescence
microscopy and variable-angle spectroscopic ellipsometry
(VASE) (Figure 1). The positive correlation between the
ﬂuorescence intensity of FN and VASE measurements is
demonstrated in the results of Figure 1B. The VASE data
additionally shows that the FN adsorption promotes a
maximum variation of 1.5 nm in the coating thickness.
Considering the poor contrast oﬀered by proteins, such a
diﬀerence in surface morphology cannot be detected by SEM,
although it poses no problem for optical techniques. The
speciﬁc adsorbed mass of FN on the PCL substrates
(calculation detailed in the Supporting Information) linearly
varied from a densely packed arrangement to a sparse FN-
molecule distribution, from ∼213 to 48 ng/cm2 along the 10
mm-long gradient (Figure 1C).
Cells receive inputs from the ECM and the soluble factors,
and process them to secrete and remodel the matrix.25,26 The
rearrangement of the adsorbed matrix proteins at the material
interface is important in guiding cell activity. In fact, the
inhibition of the FN-material reorganization, such as that
supported by covalent bonds, has been shown to prompt
proteolytic activity to degrade FN in order to introduce
microscale modiﬁcations that direct cell function.18 In our
adsorbed-FN gradient platform, the desorption of FN was only
statistically signiﬁcant at the higher-density half of the gradient
(positions 2−5 mm; Figure 2). This protein rearrangement on
the surface could be due to the fact that the newly produced
proteins (such as COL1A1 and endoFN) could not be
accommodated within the more closely packed FN layer,
forcing the FN exchange at the surface. In contrast, the
apparently intact FN density adsorbed on the lower-density half
of the gradient (positions 6−10 mm) can be the result of the
increasingly high density of bovine serum albumin (BSA)
backﬁlling the FN gradient from the ﬁrst to the tenth mm. It is
known that smaller-molecular-weight proteins and more highly
concentrated proteins are typically displaced from the surface
by larger molecular weight proteins (a competitive exchange
commonly referred as the “Vroman eﬀect”).28 For that reason,
in the lower FN density region, the BSA (a low-molecular-
weight protein27) was more prone to desorption than the high-
molecular-weight FN,29 justifying the apparently intact FN
arrangement on those regions. Overall, despite the FN surface
rearrangement, a gradient in the density range of the originally
adsorbed FN was still evident throughout the 14 days of cell
culture (Figure 2).
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Eﬀectiveness of the FN Gradient and TCPS on the
Proliferation and Osteogenic Commitment of hBM-
MSCs. At day 1, the cell density on the TCPS was not
statistically diﬀerent from the cell density at the various
positions of the FN gradient (Figure 3B). From day 1 to day 7,
however, the increase in the cell numbers across the FN
gradient ranged between 3.5- and 7-fold (Figure 3B). The
results indicate that the cell proliferation was aﬀected by the
FN-density on the surface, possibly due to the diﬀerential
exposure of the cryptic binding-sites in FN, critical for
stimulating increasing cell proliferation.30,31 At day 7, the cell
density highlighted the division of the gradient into two
functional groups: FN surface densities inducing higher cell
numbers (regions from 4 to 8 mm), and FN surface densities
inducing lower cell numbers (regions from 1 to 3 and 9 to 10
mm). Since the extremities of the FN gradient correspond to
extreme conﬂuent and sparse coverage of adsorbed FN, the lack
of a statistically signiﬁcant diﬀerence in the cell density was
unexpected. However, the similarity may be explained by the
molecular arrangement of FN in the gradient. There are several
binding sites in the FN molecule, which include both protein-
and cell-binding sites.31 Among them, there are at least four
known FN-FN binding sites. We believe that at the higher
density end of the FN gradient, the proximity between
neighboring FN molecules adsorbed on the surface may lead
to FN-FN binding, thereby hiding cell-binding sites. On the
other hand, the lower density end of the FN gradient presents a
direct correlation between lower coverage and number of cell-
binding sites. Given that hBM-MSCs are adherent cells, the
eventual reduction of the number of cell-binding sites available
may contribute to the low cell numbers in those areas. At the
same time point, TCPS supported higher cell density than all
positions of the FN gradient (0.001 < p < 0.05), except for
positions 6 and 7 mm (p > 0.05). From day 7 to day 14, the cell
number increase occurred only on positions 2, 3, and 10 mm in
the FN gradient (Figure 3B). However, even at those positions,
the cell-number expansion was substantially smaller than that
seen from day 1 to day 7.
The reduced cell proliferation is usually associated with an
increase in the diﬀerentiation commitment of BM-MSCs.32
Indeed, conﬁrming this, already at day 7 the analysis showed
that the extremities of the gradient more eﬀectively inﬂuenced
the osteoblastic induction of the stem-cell population. At those
positions, a greater cell spreading and cuboidal phenotype were
detected, particularly evident at the 10th mm in the gradient (p
< 0.001) (see Figure S1 in the Supporting Information). Both
features are linked with the commitment to the osteoblastic
lineage.33 In the same time point (day 7), on the extremities of
the gradient the osteoblastic induction was further charac-
terized by augmented 1) ALP expression and 2) synthesis of
COL1A1, both normalized to cell number (Figures 4B and 5B).
The synthesis (and presecretion stage) of COL1A1, which
was determined by the ﬂuorescence signal surrounding the cell
nucleus at day 7, was also seen on TCPS (Figure 5A). In the
same time point, the normalized COL1A1 and ALP signals
were markedly lower on the control material than at the
extremities of the FN gradient (∼4.5- to 6.5-fold and ∼5-fold,
respectively, 0.001 < p < 0.01). Remaining positions on the
gradient (i.e., 2 to 8 mm) showed comparable performance to
that of TCPS at supporting the ALP and COL1A1 expression
(p > 0.05). The data implies a diﬀerential regulation of the
osteogenic commitment of hBM-MSCs on the FN-gradient.
Moreover, density-speciﬁc FN environments have the ability to
trigger stronger osteogenic commitment than the control
material, TCPS. Increased hBM-MSC commitment to the
osteoblast lineage in the presence of FN has been previously
reported, although that study was not quantitative with respect
to FN density.34 In fact, the general limited information on the
characteristics of the protein-coatings, such as the ﬁnal protein-
density at the surface, hinders the cross-integration of the
conclusions of diﬀerent studies, and may explain apparently
conﬂicting results.35
Along the same lines (i.e., lower proliferation relating to cell
commitment to diﬀerentiation), the normalized ALP expression
on the TCPS registered a signiﬁcant increase from day 7 to day
14 (∼6.5 fold), in accordance to previously published data.35
The eﬀectiveness of the TCPS matched that of positions 7 and
9 mm in the FN gradient (p > 0.05) and surpassed the
eﬀectiveness of all other positions (0.01 < p < 0.05) with
exception of position 10 mm. In fact, the normalized ALP
expression doubled on the 10th mm on the gradient, from day
7 to day 14 (p < 0.001) (Figure 4B); as a result, it was ∼40%
higher than the control, at day 14. Moreover, also at day 14, the
normalized expression of COL1A1 increased ∼2 to 5 times on
the FN gradients (0.001 < p < 0.01), with the greatest increases
observed at the ﬁrst, ninth and tenth millimeter (Figure 5). The
normalized COL1A1 expression on TCPS was 5 to 6 times
lower than that at the extremities of the gradient, and ∼3.5 to 4
times smaller than the normalized expression at the remaining
positions (i.e., 2−8 mm), conﬁrming the positive inﬂuence of
FN on the COL1 polymerization6 even in suboptimal FN
densities. Moreover, along with the extracellular ﬁbril arrange-
ment of COL1A1 on the FN gradient and TCPS at day 14, the
strong intracellular signal of COL1A1 seen at day 7 persisted
on the FN gradient surface, but not on the TCPS (Figure 5A).
This observation seems to indicate that the continuous
synthesis of collagen, the major protein of bone, is induced
by environments where FN is steadily available, given the
Figure 3. (A) Fluorescence microscopy image representative of cell
nuclei distribution at day 1 of cell culture on the ﬁbronectin (FN)
gradients (scale bar = 1 mm). (B) Quantiﬁcation of cell nuclei on FN
gradients and tissue culture polysteryne (TCPS) at day 1, 7, and 14.
The statistical signiﬁcance of the measurements was p(x) < 0.05, p(*)
< 0.01 and p(#) < 0.001.
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regulatory role of FN on the deposition and retention of COL1
in the matrix.7,36
Interestingly, at the last time point, the expression of
COL1A1 in the matrix assumed cottony-ﬁbrillar morphology
(Figure 5A) similar to the endogenously cell-derived FN
(endoFN) on the FN gradient (Figure 6A). It has been
proposed that the assembly of FN and collagen share common
mechanistic elements, which in association with the require-
ment of FN for collagen ﬁbril assembly6 can inﬂuence in
determining the ﬁnal morphology of the COL1A1 ﬁbrils. The
morphological similarity between the COL1A1 on our FN
gradient (but not in the TCPS control) and reported FN
around osteoblasts during osteogenesis in vivo37 at the same
time point (14 days), is compelling. The similar ﬁbrillar
arrangement, here referred as in vivo-like, of the FN and
COL1A1 matrices deposited by the diﬀerentiating hBM-MSC
populations (following the introduction of the speciﬁc adsorbed
FN-density cue) may add considerable value to constructs for
bone-related applications. In fact, is has been shown that how
hMSCs proactively pull on newly assembled FN ECM ﬁbrils
aﬀects and (up)regulates hMSC osteogenesis.38 However, the
relationship between COL1A1 and FN seems to go beyond the
FN’s inﬂuence on the COL1 expression and ﬁbrillogenesis. In
this study, the presence of COL1A1 in the ECM at day 14, in
comparison to its predominant intracellular expression at day 7,
correlated with a signiﬁcant drop in the endoFN expression on
the gradient (Figure 6B). The observation seems to indicate a
control of the endoFN by the COL1A1 in the matrix, favoring
the osteogenic process. Furthermore, the diﬀerential deposition
of endoFN further highlighted the importance of total lower
FN content (i.e., endoFN plus plasma-FN) for the max-
imization of the osteogenic commitment, characterized by the
simultaneous increase of ALP and COL1A1 expression in the
ECM at position 10 mm. In comparison, higher plasma-FN
showed the ability to signiﬁcantly inﬂuence the COL1A1 but
not the ALP activity. The interaction between plasma-derived
Figure 4. Expression of alkaline phosphatase (ALP) on ﬁbronectin (FN) gradients and tissue culture polystyrene (TCPS), at days 7 and 14. (A)
Immunodetection of ALP by ﬂuorescence microscopy (scale bar = 1 mm). All square images represent 1 × 1 mm. (B) Quantiﬁcation of ALP
expression normalized to cell count. The statistical signiﬁcance of the measurements was p(*) < 0.01 and p(x) < 0.05.
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FN (as that composing the FN gradient) and collagen assembly
in bone was previously noticed in vivo.39 Moreover, in
accordance to our ﬁndings, the authors observed no eﬀect of
plasma-FN over the modulation of the osteoblastic function.
Together with the diﬀerentiation mechanism elicited by the
osteogenic induction medium, speciﬁc (low) ﬁbronectin
density signiﬁcantly aﬀected and maximized the osteoblastic
lineage commitment of the stem cell population. The inﬂuence
of the FN in the osteogenic commitment may result from the
induced changes in cell shape (see Figure S1 in the Supporting
Information), as the cytoskeleton is known to play a signiﬁcant
role in mechano-transduction and MSC diﬀerentiation.38,40
Also, the integrin expression bridging the MSCs to the
extracellular matrix proteins COL1A1 and FN may be playing
a role,34,38 as those proteins were diﬀerentially expressed at the
lower end of the FN-gradient by the cell population. The
superior results from the 10th mm of the here studied FN
density-gradient, were conﬁrmed on homogeneous samples,
indicating that paracrine signaling did not contribute to the
Figure 5. Expression of collagen type 1 alpha 1 (COL1A) on ﬁbronectin (FN) gradients and tissue culture polystyrene (TCPS), at days 7 and 14. A)
Immunodetection of COL1A1 by ﬂuorescence microscopy (scale bar = 1 mm). All square images are 1 × 1 mm. Representative intracellular
COL1A1 is indicated by arrows, whereas ﬁbrils of extracellular COL1A1are indicated by brackets. (B) Quantiﬁcation of the COL1A1 expression,
normalized to cell number. The statistical signiﬁcance of the measurements was p(#) < 0.001, p(*) < 0.01, and p(x) < 0.05.
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ﬁnal osteogenic outcome (see Figure S2 in the Supporting
Information).
■ CONCLUSIONS
The development of a surface-density gradient of FN, on a
clinically relevant polymer, as a platform to study the eﬀect of
FN density on the osteogenic commitment of hBM-MSCs was
successfully accomplished. The analysis revealed that cells
cultured in high FN-density areas showed high COL1A1
expression, but medium ALP activity. The intermediate FN
densities supported greater cell adhesion and proliferation,
which was detrimental for the osteogenic commitment. Speciﬁc
human FN density at position 10 mm in the gradient,
corresponding to ∼48 ng/cm2, consistently supported higher
cell spreading and increased expression of COL1A1 and ALP
activity, characteristic of osteoblastic diﬀerentiation, both in
comparison to the remaining positions in the gradient and to
the TCPS control We extrapolate that, given proper backﬁlling
passivation, the application of this optimal FN density on
materials of similar properties to those of PCL should promote
equivalent results as the herein reported. We thus propose a
simple and versatile strategy to signiﬁcantly enhance the
biological performance of diﬀerent synthetic materials intended
for bone-related applications involving interaction with human
mesenchymal stem cells.
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